You are viewing the site in preview mode

Skip to main content

Table 1 Course of laboratory tests over time in patient 1

From: Successful treatment of refractory hyperferritinemic syndromes with canakinumab: a report of two cases

Days from admission at Authors’ center 0 + 14 + 45a + 50 + 80
White blood cells (× 103/mm3) 17.9 10.4 44.5 11.4 8.9
Neutrophil count (×103/mm3) 15.0 8.9 41.7 6.4 5.0
Hemoglobin (g/dL) 10.3 10.6 9.3 9.8 12.5
Platelet count (×103/mm3) 482 320 418 459 315
Erythrocyte sedimentation rate (mm/h) 59 37 57 61 18
C-reactive protein (mg/dL) 8.2 4.9 11.5 1.5 <  0.46
Aspartate aminotransferase (U/L) 229 68 170 127 12
Lactate dehydrogenase (U/L) 1752 951 956 862 853
Triglycerides (mg/dL) 112 158 133 226 107
Fibrinogen (mg/dL) 341 442 415 251 287
Ferritin (ng/mL) 13,200 8550 18,000 4099 581
  1. aStart of canakinumab administration
Back to article page

Pediatric Rheumatology

ISSN: 1546-0096